Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted

OBJECTIVE: To assess whether new pharmaceutical products approved by the United States Food and Drug Administration (FDA) in 2011 and 2012 were registered, commercialized and sold at affordable prices in the Latin American countries where they were tested. METHODS: We obtained a list of new molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Homedes, Núria, Ugalde, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645434/
https://www.ncbi.nlm.nih.gov/pubmed/26600609
http://dx.doi.org/10.2471/BLT.14.151290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645434/
https://www.ncbi.nlm.nih.gov/pubmed/26600609
http://dx.doi.org/10.2471/BLT.14.151290

Ejemplares similares